Evidence map›Paper›PMID 31573929›Full record

ArticleJMIR medical informatics2019

Characterizing Artificial Intelligence Applications in Cancer Research: A Latent Dirichlet Allocation Analysis.

Bach Xuan Tran, Carl A Latkin, Noha Sharafeldin, Katherina Nguyen, Giang Thu Vu, Wilson W S Tam, Ngai-Man Cheung, Huong Lan Thi Nguyen, Cyrus S H Ho, Roger C M Ho

Open access · goldAbstract read
In one paragraph

Article in JMIR medical informatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. [Research on interdisciplinary issues of artificial intelligence medical devices].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Bach Xuan TranInstitute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.ORCID http://orcid.org/0000-0001-7827-8449
Carl A LatkinBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.ORCID http://orcid.org/0000-0002-7931-2116
Noha SharafeldinDivision of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.ORCID http://orcid.org/0000-0001-8835-8899
Katherina NguyenDepartment of Science, Technology, and Society, Stanford University, Palo Alto, CA, United States.ORCID http://orcid.org/0000-0002-6186-3374
Giang Thu VuCenter of Excellence in Evidence-based Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.ORCID http://orcid.org/0000-0002-3470-4458
Wilson W S TamAlice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0641-3060
Ngai-Man CheungCenter of Excellence in Artificial Intelligence in Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.ORCID http://orcid.org/0000-0003-0135-3791
Huong Lan Thi NguyenInstitute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam.ORCID http://orcid.org/0000-0003-2458-1666
Cyrus S H HoDepartment of Psychological Medicine, National University Hospital, Singapore, Singapore.ORCID http://orcid.org/0000-0002-7092-9566
Roger C M HoCenter of Excellence in Behavior Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.ORCID http://orcid.org/0000-0001-9629-4493
Johns Hopkins University · USNational University of Singapore · SGDuy Tan University · VNNational University Hospital · SGSingapore University of Technology and Design · SGStanford University · USTrường ĐH Nguyễn Tất Thành · VNUniversity of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArtificial intelligence (AI)-based therapeutics, devices, and systems are vital innovations in cancer control; particularly, they allow for diagnosis, screening, precise estimation of survival, informing therapy selection, and scaling up treatment services in a timely manner.

objectiveThe aim of this study was to analyze the global trends, patterns, and development of interdisciplinary landscapes in AI and cancer research.

methodsAn exploratory factor analysis was conducted to identify research domains emerging from abstract contents. The Jaccard similarity index was utilized to identify the most frequently co-occurring terms. Latent Dirichlet Allocation was used for classifying papers into corresponding topics.

resultsFrom 1991 to 2018, the number of studies examining the application of AI in cancer care has grown to 3555 papers covering therapeutics, capacities, and factors associated with outcomes. Topics with the highest volume of publications include (1) machine learning, (2) comparative effectiveness evaluation of AI-assisted medical therapies, and (3) AI-based prediction. Noticeably, this classification has revealed topics examining the incremental effectiveness of AI applications, the quality of life, and functioning of patients receiving these innovations. The growing research productivity and expansion of multidisciplinary approaches are largely driven by machine learning, artificial neural networks, and AI in various clinical practices.

conclusionsThe research landscapes show that the development of AI in cancer care is focused on not only improving prediction in cancer screening and AI-assisted therapeutics but also on improving other corresponding areas such as precision and personalized medicine and patient-reported outcomes.

Indexed as

artificial intelligencecancerglobalmappingscientometrics

Identifiers

PMID31573929
PMCPMC6774235
OpenAlexW2963943051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.